• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甘露糖结合凝集素在人类肾小球肾炎中的肾小球沉积。

Glomerular deposition of mannose-binding lectin in human glomerulonephritis.

作者信息

Lhotta K, Würzner R, König P

机构信息

Department of Internal Medicine, Innsbruck University Hospital, Austria.

出版信息

Nephrol Dial Transplant. 1999 Apr;14(4):881-6. doi: 10.1093/ndt/14.4.881.

DOI:10.1093/ndt/14.4.881
PMID:10328463
Abstract

BACKGROUND

Mannose-binding lectin (MBL), a member of the collectin family, binds to various oligosaccharides and activates the classical pathway of complement independent from C1q. At present it is unknown whether this so-called lectin pathway of complement activation plays a role in the pathogenesis of human glomerulonephritis.

METHODS

Direct immunofluorescence of 84 renal biopsies using an MBL-specific monoclonal antibody and antibodies directed against IgG, IgA, IgM, C1q, C3, and terminal complement complex (TCC) was performed. Serum MBL levels of 50 patients were determined by enzyme-linked immunosorbent assay.

RESULTS

MBL was detected in the glomeruli of patients with lupus nephropathy (15 of 16), membranous nephropathy (10/15), membranoproliferative glomerulonephritis type I (5/6) and anti-GBM nephritis (2/4). MBL deposition paralleled that of immunoglobulins, C1q, C3, and TCC but was less intense as compared to C1q. Focal segmental deposits of MBL were present in focal segmental glomerulosclerosis (4/6), IgA nephropathy (3/11), amyloidosis AL (1/4), and advanced renal fibrosis (2/2). Here MBL staining was identical to IgM and C3 and considered an unspecific entrapment of MBL in sclerotic lesions in these cases. No significant difference in MBL serum levels was observed between normal controls and patients with lupus nephritis, membranous nephropathy, membranoproliferative glomerulonephritis, focal segmental sclerosis, minimal change disease or IgA nephropathy. In patients suffering from membranous nephropathy with (n=10) or without (n=5) glomerular MBL deposits serum creatinine, C3, C4, serum protein, and proteinuria were not statistically different.

CONCLUSION

MBL is present in the glomeruli of patients with glomerulonephritis involving deposition of IgG and activation of the classical pathway of complement. We propose that MBL binds to agalactosyl oligosaccharides of IgG that terminate in N-acetylglucosamine. The extent to which the lectin pathway of complement contributes to overall complement activation in the glomeruli remains unknown, but is likely to be marginal.

摘要

背景

甘露糖结合凝集素(MBL)是胶原凝集素家族的一员,可与多种寡糖结合,并独立于C1q激活补体经典途径。目前尚不清楚这种所谓的补体凝集素途径是否在人类肾小球肾炎的发病机制中起作用。

方法

使用MBL特异性单克隆抗体以及针对IgG、IgA、IgM、C1q、C3和末端补体复合物(TCC)的抗体,对84份肾活检组织进行直接免疫荧光检测。采用酶联免疫吸附测定法测定50例患者的血清MBL水平。

结果

在狼疮性肾炎患者(16例中的15例)、膜性肾病患者(15例中的10例)、I型膜增生性肾小球肾炎患者(6例中的5例)和抗肾小球基底膜肾炎患者(4例中的2例)的肾小球中检测到MBL。MBL沉积与免疫球蛋白、C1q、C3和TCC的沉积平行,但与C1q相比强度较弱。在局灶节段性肾小球硬化症(6例中的4例)、IgA肾病(11例中的3例)、AL型淀粉样变性(4例中的1例)和晚期肾纤维化患者(2例中的2例)中存在MBL的局灶节段性沉积。在这些病例中,MBL染色与IgM和C3相同,被认为是MBL在硬化病变中的非特异性截留。在正常对照组与狼疮性肾炎、膜性肾病、膜增生性肾小球肾炎、局灶节段性硬化症、微小病变病或IgA肾病患者之间,未观察到MBL血清水平的显著差异。在有(n = 10)或无(n = 5)肾小球MBL沉积的膜性肾病患者中,血清肌酐、C3、C4、血清蛋白和蛋白尿在统计学上无差异。

结论

MBL存在于伴有IgG沉积和补体经典途径激活的肾小球肾炎患者的肾小球中。我们提出MBL与以N - 乙酰葡糖胺结尾的IgG的半乳糖基寡糖结合。补体凝集素途径在肾小球中对整体补体激活的贡献程度尚不清楚,但可能很小。

相似文献

1
Glomerular deposition of mannose-binding lectin in human glomerulonephritis.甘露糖结合凝集素在人类肾小球肾炎中的肾小球沉积。
Nephrol Dial Transplant. 1999 Apr;14(4):881-6. doi: 10.1093/ndt/14.4.881.
2
Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy.甘露糖结合凝集素(MBL)在肾小球的沉积表明了IgA肾病中补体激活的一种新机制。
Nephrol Dial Transplant. 1998 Aug;13(8):1984-90. doi: 10.1093/ndt/13.8.1984.
3
Activation of the lectin complement pathway in post-streptococcal acute glomerulonephritis.链球菌感染后急性肾小球肾炎中凝集素补体途径的激活
Pathol Int. 2007 Jun;57(6):351-7. doi: 10.1111/j.1440-1827.2007.02107.x.
4
Mesangial IgA2 deposits and lectin pathway-mediated complement activation in IgA glomerulonephritis.IgA 肾小球肾炎中的系膜 IgA2 沉积及凝集素途径介导的补体激活
Am J Kidney Dis. 2001 Nov;38(5):1082-8. doi: 10.1053/ajkd.2001.28611.
5
Immunohistopathologic evaluation of C1q in 800 renal biopsy specimens.对800份肾活检标本进行C1q的免疫组织病理学评估。
Am J Clin Pathol. 1985 Apr;83(4):415-20. doi: 10.1093/ajcp/83.4.415.
6
Deposition of the lectin pathway of complement in renal biopsies of lupus nephritis patients.狼疮肾炎患者肾活检中补体凝集素途径的沉积。
Hum Immunol. 2013 Aug;74(8):907-10. doi: 10.1016/j.humimm.2013.04.030. Epub 2013 Apr 29.
7
Human IgA activates the complement system via the mannan-binding lectin pathway.人IgA通过甘露聚糖结合凝集素途径激活补体系统。
J Immunol. 2001 Sep 1;167(5):2861-8. doi: 10.4049/jimmunol.167.5.2861.
8
Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease.IgA肾病中补体凝集素途径的肾小球激活与更严重的肾脏疾病相关。
J Am Soc Nephrol. 2006 Jun;17(6):1724-34. doi: 10.1681/ASN.2005090923. Epub 2006 May 10.
9
Deposition of mannan binding protein and mannan binding protein-mediated complement activation in the glomeruli of patients with IgA nephropathy.甘露聚糖结合蛋白的沉积及甘露聚糖结合蛋白介导的补体激活在IgA肾病患者肾小球中的情况。
Nephron. 1998 Dec;80(4):408-13. doi: 10.1159/000045212.
10
Complement activation through the lectin pathway in patients with Henoch-Schönlein purpura nephritis.过敏性紫癜性肾炎患者中通过凝集素途径的补体激活。
Am J Kidney Dis. 2000 Mar;35(3):401-7. doi: 10.1016/s0272-6386(00)70192-2.

引用本文的文献

1
Newer B-cell and plasma-cell targeted treatments for rituximab-resistant patients with membranous nephropathy.针对利妥昔单抗耐药的膜性肾病患者的新型B细胞和浆细胞靶向治疗方法。
Clin Kidney J. 2025 Mar 21;18(5):sfaf088. doi: 10.1093/ckj/sfaf088. eCollection 2025 May.
2
variants contribute to FSGS susceptibility across multiple populations.多种变异在多个群体中导致局灶节段性肾小球硬化易感性。
iScience. 2025 Mar 18;28(4):112234. doi: 10.1016/j.isci.2025.112234. eCollection 2025 Apr 18.
3
Therapeutic targets in membranous nephropathy: plasma cells and complement.
膜性肾病的治疗靶点:浆细胞与补体
Clin Kidney J. 2024 Aug 13;17(9):sfae243. doi: 10.1093/ckj/sfae243. eCollection 2024 Sep.
4
variants contribute to FSGS susceptibility across multiple populations.多种变异体在多个群体中导致局灶节段性肾小球硬化易感性。
medRxiv. 2023 Nov 20:2023.11.20.23298462. doi: 10.1101/2023.11.20.23298462.
5
Unleashing the power of complement activation: unraveling renal damage in human anti-glomerular basement membrane disease.释放补体激活的力量:揭示人类抗肾小球基底膜病中的肾损伤机制。
Front Immunol. 2023 Sep 15;14:1229806. doi: 10.3389/fimmu.2023.1229806. eCollection 2023.
6
Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy.当前对补体蛋白作为治疗免疫球蛋白 A 肾病的治疗靶点的理解。
Drugs. 2023 Nov;83(16):1475-1499. doi: 10.1007/s40265-023-01940-2. Epub 2023 Sep 25.
7
Immune regulatory networks coordinated by glycans and glycan-binding proteins in autoimmunity and infection.糖链和糖结合蛋白协调的自身免疫和感染中的免疫调节网络。
Cell Mol Immunol. 2023 Oct;20(10):1101-1113. doi: 10.1038/s41423-023-01074-1. Epub 2023 Aug 15.
8
Lectin Complement Pathway Activation is Associated with Massive Proteinuria in PLA2R-Positive Membranous Nephropathy: A Retrospective Study.凝集素补体途径激活与PLA2R阳性膜性肾病的大量蛋白尿相关:一项回顾性研究
Int J Gen Med. 2023 May 17;16:1879-1889. doi: 10.2147/IJGM.S407073. eCollection 2023.
9
The classical pathway triggers pathogenic complement activation in membranous nephropathy.经典途径触发膜性肾病中的致病补体激活。
Nat Commun. 2023 Jan 28;14(1):473. doi: 10.1038/s41467-023-36068-0.
10
Kidney diseases.肾脏疾病。
Immunol Rev. 2023 Jan;313(1):239-261. doi: 10.1111/imr.13167. Epub 2022 Nov 12.